Nurix Therapeutics: HC Wainwright Raises Buy PT to $32, Keeps Buy Rating.

martes, 24 de marzo de 2026, 7:01 am ET1 min de lectura
NRIX--

Nurix Therapeutics: HC Wainwright Raises Buy PT to $32, Keeps Buy Rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios